tiprankstipranks

Devonian Health Group Resumes Trading on TSXV

Story Highlights
Devonian Health Group Resumes Trading on TSXV

Don’t Miss TipRanks’ Half-Year Sale

Devonian Health Group ( (TSE:GSD) ) has provided an announcement.

Devonian Health Group announced the reinstatement of its common shares on the TSX Venture Exchange following the resolution of a cease trade order due to delayed financial filings. The company has reaffirmed its commitment to compliance and governance, which may positively impact its market position and reassure stakeholders.

More about Devonian Health Group

Devonian Health Group is a clinical stage pharmaceutical company based in Québec, Canada, specializing in the development of drugs for autoimmune inflammatory conditions and cosmeceutical products. The company focuses on innovative therapeutic approaches to address unmet medical needs, particularly in diseases like ulcerative colitis and atopic dermatitis. Devonian also operates a commercialization subsidiary, Altius Healthcare Inc., which sells prescription pharmaceutical products in Canada.

YTD Price Performance: 12.50%

Average Trading Volume: 23,247

Technical Sentiment Signal: Buy

Current Market Cap: C$26.68M

For an in-depth examination of GSD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1